Cognitive Disorders | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

48,601 results for “Cognitive Disorders”

Trials

View all 42770 →

Remote Cognitive Multidomain Assessment in People With Cognitive Disorders

114 participants · First posted Oct 11, 2023

Long-term Outcome of General Anesthesia on Dysgnosia

10,000 participants · First posted Aug 19, 2010

Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients

20 participants · First posted Aug 23, 2016

Drugs

View all 336 →

GPR151 modulators (cognitive disorders/ Schizophrenia)

alpha 7 nicotinic acetylcholine receptor positive allosteric modulators (cognitive disorders)

Digital cognitive behavioral therapy

Organizations

View all 94 →

Institute For Neurodegenerative Disorders

United States

Gibson Institute of Cognitive Research

United States

F.C. Donders Centre for Cognitive Neuroimaging

News

View all 5401 →

ACTG Launches Phase 2 Trial Comparing Pramipexole to Escitalopram for Depression and Cognitive Disorders in HIV Patients

Suven Life Sciences Initiates Phase 1 Trial of SUVN-I6107 for Cognitive Disorders

GLP-1 Diabetes Drugs Show Promising Potential for Mental Health Treatment

Page 1 of 4861